World's Best Scientists 2026 revealed!
Sylvie Lantuejoul

Sylvie Lantuejoul

Overview

Sylvie Lantuejoul is affiliated with Grenoble Alpes University in France and has contributed extensively to the fields of pulmonary and respiratory medicine, oncology, and molecular biology. Their research covers a spectrum of topics related to lung diseases and cancer, focusing particularly on lung cancer treatments, mutations, and molecular diagnostics.

Their main fields of study include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Sylvie Lantuejoul's subfields of study highlight specialization areas such as:

  • Pulmonary and Respiratory Medicine
  • Oncology
  • Molecular Biology
  • Epidemiology
  • Cancer Research

Primary topics addressed in their work encompass:

  • Lung Cancer Treatments and Mutations
  • Occupational and Environmental Lung Diseases
  • Lung Cancer Research Studies
  • Neuroendocrine Tumor Research Advances
  • Cancer Genomics and Diagnostics
  • Pleural and Pulmonary Diseases
  • RNA Modifications and Cancer

Their contributions have been published frequently in a variety of journals, with the most publications appearing in:

  • Journal of Thoracic Oncology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Revue des Maladies Respiratoires Actualités
  • ESMO Open
  • Clinical Cancer Research

Recent published papers by Sylvie Lantuejoul include:

  • The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015 (2021, Journal of Thoracic Oncology)
  • Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (2021, Annals of Oncology)
  • A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee (2020, Journal of Thoracic Oncology)
  • The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee (2020, Journal of Thoracic Oncology)
  • The International Association for the Study of Lung Cancer Global Survey on Molecular Testing in Lung Cancer (2020, Journal of Thoracic Oncology)

Sylvie Lantuejoul has collaborated frequently with several researchers, including:

  • Nicolas Girard
  • Francesca Damiola
  • Matthieu Foll
  • Lynnette Fernandez-Cuesta
  • Arnaud Scherpereel

Best Publications

  • Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer

    Martin Peifer;Lynnette Fernández-Cuesta;Martin L. Sos;Julie George

  • Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)

    Fabrice Barlesi;Julien Mazieres;Jean-Philippe Merlio;Didier Debieuvre

  • The 2021 WHO Classification of Lung Tumors: Impact of advances since 2015.

    Andrew G. Nicholson;Ming S. Tsao;Mary Beth Beasley;Alain C. Borczuk

  • PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project.

    Ming Sound Tsao;Keith M. Kerr;Mark Kockx;Mary Beth Beasley

  • A genomics-based classification of human lung tumors

    Danila Seidel;Thomas Zander;Lukas C. Heukamp;Martin Peifer

  • Ectopic Activation of Germline and Placental Genes Identifies Aggressive Metastasis-Prone Lung Cancers

    Sophie Rousseaux;Alexandra Debernardi;Baptiste Jacquiau;Anne Laure Vitte

  • Nivolumab or nivolumab plus ipilimumab in patients with relapsed malignant pleural mesothelioma (IFCT-1501 MAPS2): a multicentre, open-label, randomised, non-comparative, phase 2 trial

    Arnaud Scherpereel;Julien Mazieres;Laurent Greillier;Sylvie Lantuejoul

  • TUNEL Apoptotic Cell Detection in Tissue Sections: Critical Evaluation and Improvement

    Françoise Labat-Moleur;Christiane Guillermet;Philippe Lorimier;Catherine Robert

  • Preoperative Circulating Tumor Cell Detection Using the Isolation by Size of Epithelial Tumor Cell Method for Patients with Lung Cancer Is a New Prognostic Biomarker

    Véronique Hofman;Christelle Bonnetaud;Marius I. Ilie;Philippe Vielh

  • Apoptosis-related factors p53, Bcl2, and Bax in neuroendocrine lung tumors.

    E. Brambilla;A. Negoescu;S. Gazzeri;S. Lantuejoul

  • A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee.

    Andre L. Moreira;Paolo S.S. Ocampo;Yuhe Xia;Hua Zhong

  • Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆

    A.-M.C. Dingemans;M. Früh;A. Ardizzoni;B. Besse

  • Prognostic Effect of Tumor Lymphocytic Infiltration in Resectable Non–Small-Cell Lung Cancer

    Elisabeth Brambilla;Gwénaël Le Teuff;Sophie Marguet;Sylvie Lantuejoul

  • Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer

    Yasushi Yatabe;Sanja Dacic;Alain C. Borczuk;Arne Warth

  • SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas.

    Francois Le Loarer;Francois Le Loarer;Sarah Watson;Gaelle Pierron;Vincent Thomas de Montpreville

  • Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors

    Julie George;Vonn Walter;Vonn Walter;Martin Peifer;Ludmil B. Alexandrov

  • CD74-NRG1 fusions in lung adenocarcinoma

    Lynnette Fernandez-Cuesta;Dennis Plenker;Hirotaka Osada;Ruping Sun

  • Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection

    Ming Sound Tsao;Sophie Marguet;Gwénaël Le Teuff;Sylvie Lantuejoul

  • The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working group

    Erik Thunnissen;Keith Kerr;Felix F.J.F. Herth;Sylvie Lantuejoul

  • Pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis: a clinicopathologic study of 35 cases.

    Sylvie Lantuejoul;Mary N. Sheppard;Bryan Corrin;Margaret M. Burke

Frequent Co-Authors

Elisabeth Brambilla
Elisabeth Brambilla Grenoble Alpes University
Christian Brambilla
Christian Brambilla Centre national de la recherche scientifique, CNRS
Nicolas Girard
Nicolas Girard Institute Curie
Keith M. Kerr
Keith M. Kerr Aberdeen Royal Infirmary
Andrew G. Nicholson
Andrew G. Nicholson Royal Brompton Hospital
William D. Travis
William D. Travis Memorial Sloan Kettering Cancer Center
Benjamin Besse
Benjamin Besse University of Paris-Saclay
Yasushi Yatabe
Yasushi Yatabe Nagoya University
Ming-Sound Tsao
Ming-Sound Tsao Princess Margaret Cancer Centre
Mari Mino-Kenudson
Mari Mino-Kenudson Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring options beyond traditional medical school can open up rewarding healthcare careers with more flexible study paths. For those interested in administrative or technical roles, financial aid for medical billing and coding online classes makes it possible to start a healthcare career without incurring heavy debt, while studying on your own schedule.

Nursing remains a top choice for many students, and there are now nursing school without teas test options that remove common barriers during the application process, making the transition to a nursing career more accessible.

Those seeking to move into leadership positions can consider a health care administration degree online, which allows you to build business and organizational skills tailored to the healthcare sector.

Registered nurses looking to advance can apply to specialized programs such as adn to msn bridge programs. These bridging degrees are designed for working professionals seeking to earn a master’s degree without starting from scratch.

Each of these pathways offers unique opportunities for students to join the healthcare field, whether at the entry, advancement, or leadership level—all with flexible online options.

Best Scientists Citing Sylvie Lantuejoul

Trending Scientists